Price Thomas Edmunds 4/A

What Happened

• Thomas Edmunds, a director of P3 Health Partners Inc. (PIII), was granted 2,000 restricted stock units (RSUs) on August 6, 2025. The grant was reported as an award (Code A) at $0.00 per share (no cash paid). Each RSU represents a right to receive one share of Class A common stock upon vesting.

Key Details

• Transaction date and type: 2025-08-06 — Grant/Award (2,000 RSUs) at $0.00 per RSU.
• Vesting: RSUs vest upon the earlier of the company's 2026 annual stockholder meeting and the one-year anniversary of the grant date (per footnote).
• Shares owned after transaction: Not specified in the supplied filing excerpt (the amended Form 4 corrects prior reported ownership to reflect a 1-for-50 reverse split).
• Filing status: This is an amended Form 4 filed on 2026-01-23 to correct Column 5 (beneficial ownership) following the April 11, 2025 1-for-50 reverse stock split; the amendment states it was filed solely to correct the post-split ownership numbers.

Context

• RSU grants are a common form of equity compensation for directors and typically convert into shares upon vesting; they are not an open-market purchase or sale and don’t by themselves indicate immediate buying/selling sentiment.
• The amendment relates to reporting accuracy after a corporate reverse split rather than a change in the underlying grant terms.